Clinical presentation of juvenile Huntington disease
- PMID: 16622544
- DOI: 10.1590/s0004-282x2006000100002
Clinical presentation of juvenile Huntington disease
Abstract
Objective: To describe the clinical presentation a group of patients with juvenile onset of Huntington disease.
Method: All patients were interviewed following a structured clinical questionnaire. Patients were genotyped for the trinucleotide cytosine-adenine-guanine (CAG) repeat in the Huntington Disease gene. High resolution brain MRI was performed in all patients.
Results: We identified 4 patients with juvenile onset of disease among 50 patients with Huntington disease followed prospectively in our Neurogenetics clinic. Age at onset varied from 3 to 13 years, there were 2 boys, and 3 patients had a paternal inheritance of the disease. Expanded Huntington disease allele sizes varied from 41 to 69 trinucleotide repeats. The early onset patients presented with rigidity, bradykinesia, dystonia, dysarthria, seizures and ataxia. MRI showed severe volume loss of caudate and putamen nuclei (p=0.001) and reduced cerebral and cerebellum volumes (p=0.01).
Conclusion: 8% of Huntington disease patients seen in our clinic had juvenile onset of the disease. They did not present with typical chorea as seen in adult onset Huntington disease. There was a predominance of rigidity and bradykinesia. Two other important clinical features were seizures and ataxia, which related with the imaging findings of early cortical atrophy and cerebellum volume loss.
Similar articles
-
Longitudinal analysis of regional grey matter loss in Huntington disease: effects of the length of the expanded CAG repeat.J Neurol Neurosurg Psychiatry. 2008 Feb;79(2):130-5. doi: 10.1136/jnnp.2007.116244. Epub 2007 Jul 5. J Neurol Neurosurg Psychiatry. 2008. PMID: 17615168
-
[Clinical and genetic study of juvenile form of Huntington's disease].Neurol Neurochir Pol. 2002 Mar-Apr;36(2):245-58. Neurol Neurochir Pol. 2002. PMID: 12046502 Polish.
-
Striatal and extrastriatal atrophy in Huntington's disease and its relationship with length of the CAG repeat.Braz J Med Biol Res. 2006 Aug;39(8):1129-36. doi: 10.1590/s0100-879x2006000800016. Braz J Med Biol Res. 2006. PMID: 16906288
-
Juvenile Huntington's disease: does a dosage-effect pathogenic mechanism differ from the classical adult disease?Mech Ageing Dev. 2006 Feb;127(2):208-12. doi: 10.1016/j.mad.2005.09.012. Epub 2005 Nov 7. Mech Ageing Dev. 2006. PMID: 16274727 Review.
-
[A case of adult-onset Huntington disease presenting with spasticity and cerebellar ataxia, mimicking spinocerebellar degeneration].Rinsho Shinkeigaku. 2003 Jan-Feb;43(1-2):16-9. Rinsho Shinkeigaku. 2003. PMID: 12820545 Review. Japanese.
Cited by
-
Cerebellum in Alzheimer's disease and other neurodegenerative diseases: an emerging research frontier.MedComm (2020). 2024 Jul 13;5(7):e638. doi: 10.1002/mco2.638. eCollection 2024 Jul. MedComm (2020). 2024. PMID: 39006764 Free PMC article. Review.
-
Neuropathological Comparison of Adult Onset and Juvenile Huntington's Disease with Cerebellar Atrophy: A Report of a Father and Son.J Huntingtons Dis. 2017;6(4):337-348. doi: 10.3233/JHD-170261. J Huntingtons Dis. 2017. PMID: 29036832 Free PMC article.
-
Clinical Manifestation of Juvenile and Pediatric HD Patients: A Retrospective Case Series.Brain Sci. 2020 Jun 3;10(6):340. doi: 10.3390/brainsci10060340. Brain Sci. 2020. PMID: 32503138 Free PMC article.
-
No Evidence of Early Developmental Delay in Juvenile-Onset Huntington's Disease Patients.Mov Disord Clin Pract. 2025 Mar;12(3):346-352. doi: 10.1002/mdc3.14287. Epub 2024 Dec 7. Mov Disord Clin Pract. 2025. PMID: 39644245 Free PMC article.
-
Disruption of Purkinje cell function prior to huntingtin accumulation and cell loss in an animal model of Huntington disease.Exp Neurol. 2012 Jul;236(1):171-8. doi: 10.1016/j.expneurol.2012.04.015. Epub 2012 May 2. Exp Neurol. 2012. PMID: 22579526 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical